Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Tue Apr 01 20:32:18 GMT 2025
by
admin
on
Tue Apr 01 20:32:18 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | BACTERIUM |
| Source Materials State | INACTIVATED |
| Source Materials Parent | |
| Infraspecific Type | STRAIN |
| Infraspecific Name | 1482 |
| Part | capsule |
| Fraction Material Type | polysaccharide |
| Fraction Name | polyribosyl-ribitol-phosphate |
| Record UNII |
FLV5I5W26R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000183888
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
N0000170916
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY | Vaccines, Inactivated [Chemical/Ingredient] | ||
|
C77710
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY | |||
|
N0000183364
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY | Actively Acquired Immunity [PE] | ||
|
N0000170883
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY | Haemophilus Vaccines [Chemical/Ingredient] | ||
|
FLV5I5W26R
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY | |||
|
FLV5I5W26R
Created by
admin on Tue Apr 01 20:32:18 GMT 2025 , Edited by admin on Tue Apr 01 20:32:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->VACCINE ANTIGEN |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| PROTEIN CONJUGATION |
Amount:
|
TETANUS TOXOID | 62f43f7f | |||
| FRAGMENT | ADIPIC ACID DIHYDRAZIDE | VK98I9YW5M |